Related Experiment Video
Updated: Sep 14, 2025

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
Published on: November 1, 2024
Drug Development in Abu Dhabi: Advancing Innovation Through Government Support and a Thriving Ecosystem
Namir Shaabani1,2, Aleh Ibrahim Saleh2, Mohamed Salem Alameri3
1Attentive Science LTD, Masdar City, Abu Dhabi, UAE.
Abstract:
Drug development is a complex, high-risk, and resource-intensive process, with global challenges such as high costs, regulatory hurdles, and low clinical trial success rates. These obstacles are especially acute for biotech startups and companies in emerging markets, where access to infrastructure, patient populations, and capital can be limited. This Perspective advocates for Abu Dhabi's emerging life sciences ecosystem as a potential framework for other regions seeking to accelerate pharmaceutical innovation. By offering government-backed incentives, advanced research infrastructure, regulatory support, and access to regional genomic data, Abu Dhabi provides a model for addressing industry bottlenecks and fostering sustainable drug development growth in new markets.
Related Concept Videos
Preclinical Development: Overview
Drug Discovery: Overview
Clinical Trials: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

